Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

SCFSkp2 complex targeted by Epstein-Barr virus essential nuclear antigen.

Jason S Knight1, Nikhil Sharma, Erle S Robertson

  • 1Department of Microbiology and Abramson Comprehensive Cancer Center, University of Pennsylvania Medical School, 201E Johnson Pavilion, 3610 Hamilton Walk, Philadelphia, PA 19104, USA.

Molecular and Cellular Biology
|February 17, 2005
PubMed
Summary

Epstein-Barr virus nuclear antigen 3C (EBNA3C) hijacks the SCFSkp2 complex to degrade the cell cycle inhibitor p27. This viral usurpation of the ubiquitin-proteasome system offers a new mechanism for EBV-driven cancer development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association between HPV-16 and HPV-18 viral loads and severity of cervical pre-invasive lesions in women with and without HIV in Botswana.

Frontiers in oncology·2026
Same author

Endothelial cell-derived plasminogen activator inhibitor-1 potentiates thrombosis in antiphospholipid syndrome.

Journal of autoimmunity·2026
Same author

Correction: A proteomic map of thromboinflammatory signatures in antiphospholipid syndrome: results from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) registry.

Frontiers in immunology·2026
Same author

Do ethnoracial differences exist among antiphospholipid antibody-positive patients with no other systemic autoimmune diseases: results from the APS ACTION registry.

Advances in rheumatology (London, England)·2026
Same author

Neutrophils and monocytes in the pathogenesis of antiphospholipid syndrome.

Current opinion in immunology·2026
Same author

Antiphospholipid antibodies and cardiovascular thrombosis.

Nature reviews. Cardiology·2026

Area of Science:

  • Molecular Biology
  • Virology
  • Cancer Biology

Background:

  • Cell cycle protein stability is regulated by the ubiquitin-proteasome system.
  • The E3 ubiquitin ligase SCFSkp2 targets key cell cycle proteins like p27, E2F, and c-myc for degradation.
  • Dysregulation of SCFSkp2 is implicated in human cancers.

Purpose of the Study:

  • To investigate the role of Epstein-Barr virus (EBV) nuclear antigen 3C (EBNA3C) in cell cycle regulation.
  • To elucidate the mechanism by which EBV influences the SCFSkp2 complex and its targets.

Main Methods:

  • Investigated the association of EBNA3C with cyclin A/cdk2 complexes.
  • Assessed the impact of EBNA3C on the stability of the kinase inhibitor p27.
  • Examined the recruitment of SCFSkp2 activity to cyclin A complexes by EBNA3C.

Related Experiment Videos

Main Results:

  • EBNA3C binds to cyclin A/cdk2 complexes, disrupting p27 and increasing kinase activity.
  • EBNA3C facilitates the recruitment of SCFSkp2 to cyclin A complexes.
  • This interaction leads to the ubiquitination and degradation of p27.

Conclusions:

  • EBNA3C usurps the SCFSkp2 ubiquitin ligase machinery to control p27 stability.
  • This represents a novel mechanism for EBV to regulate cell cycle progression.
  • Understanding this interaction provides insights into EBV-associated oncogenesis.